| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Director, 10% Owner
8 companies
Healy James is a Director at PDSB with holdings across 8 companies. Recent SEC Form 4 filings include 25 buys and 7 sells.
Estimated insider holdings value: $77.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 27, 2024 | BIOA Bioage Labs, Inc. | Director | Buy | 666,665 | $18.00 | $11,999,970.00 | +40.7% | -72.0% | -74.2% | |
| Jul 1, 2024 | RAPP Rapport Therapeutics, Inc. | Director | Buy | 44,032 | $24.52 | $1,079,575.36 | +12.7% | -19.5% | -55.5% | |
| Jun 10, 2024 | RAPP Rapport Therapeutics, Inc. | Director | Buy | 558,824 | $17.00 | $9,500,008.00 | +40.1% | -24.9% | -49.8% | |
| Jan 30, 2024 | AVBP Arrivent Biopharma, Inc. | Director | Buy | 444,444 | $18.00 | $7,999,992.00 | +35.5% | -25.7% | +31.9% | |
| Dec 13, 2023 | NTRA Natera, Inc. | Director | Sell | 644,000 | $58.75 | $37,835,000.00 | -100% | +51.1% | +177.0% | |
| Nov 16, 2022 | NTRA Natera, Inc. | Director | Sell | 2,400 | $37.71 | $90,498.00 | -100% | +14.5% | +43.8% | |
| Sep 29, 2021 | CHRS Coherus Oncology, Inc. | Director | Sell | 434,555 | $16.68 | $7,250,063.05 | -41.2% | +5.2% | -43.2% | |
| Jul 22, 2021 | NTRA Natera, Inc. | Director | Buy | 2,400 | $113.00 | $271,200.00 | New | -3.8% | -61.7% | |
| Feb 9, 2021 | BOLT Bolt Biotherapeutics, Inc. | Director | Buy | 450,000 | $20.00 | $9,000,000.00 | +19.5% | - | - | |
| Jul 2, 2019 | CHRS Coherus Oncology, Inc. | Director | Sell | 360,000 | $22.30 | $8,027,600.00 | -8.2% | - | - |